Concepedia

Miriam Galbusera

MG

47

Publications

5.6K

Citations

30

H-Index

1988

Active since

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Ospedale Papa Giovanni XXIII

Azienda Ospedaliero Universitaria Ospedali Riuniti

University of Milan

Miriam Galbusera is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1988–2023

47

Publications

47

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

Miha Furlan, Rodolfo Robles, Miriam Galbusera et al. · New England Journal of Medicine · 1998 · 1.7K citations · Full text

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Timothy H.J. Goodship, H. Terence Cook, Fádi Fakhouri et al. · Kidney International · 2016 · 674 citations · Full text

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi et al. · Blood · 2014 · 327 citations · Full text

Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis

Marina Morigi, Miriam Galbusera, Sara Gastoldi et al. · The Journal of Immunology · 2011 · 230 citations · Full text

, , +19

Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.

Judith Dent, Miriam Galbusera, Zaverio M. Ruggeri · Journal of Clinical Investigation · 1991 · 197 citations · Full text

, , +14

Rows per page

1–5 of 47